The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world (RW) treatment (tx) patterns and clinical outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) in the US community setting.
 
Cherrishe Brown-Bickerstaff
Employment - Cardinal Health; Ontada/McKesson
Stock and Other Ownership Interests - Abbvie; Walgreens Boots Alliance
Research Funding - Ascentage Pharma (Inst); Blue Note Therapeutics; Bristol Myers Squibb (Inst); Celgene/Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Eisai (Inst); EmitBio (Inst); Exelixis (Inst); Greenwich Biosciences (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
 
Paul Conkling
Employment - Ontada/McKesson; Virginia Oncology Associates
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly; EMD Serono (Inst); Janssen (Inst)
 
Rosa Banuelos
No Relationships to Disclose
 
Jose Perez-Torrealba
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
Travel, Accommodations, Expenses - Exelixis
 
Tasha Hall
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Navendu Samant
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
Travel, Accommodations, Expenses - Exelixis
 
Yue Zhang
Employment - Virginia Oncology Associates
Consulting or Advisory Role - Daiichi Sankyo; Ipsen; Ontada/McKesson
Speakers' Bureau - Merck